Clinical Trial

Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma

Study acronym: LIVERCARE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 18, 2017 (before its estimated July 10, 2022 completion). Its status may not reflect the trial's current state.
Summary
Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer. Patients will receive work-up, treatment and follow-up exclusively as routinely done except additional quality of life measurements. Qol will be measured by standardized and validated EORTC questionaires at different time points during routine follow-up.
Trial Details
NCT Number NCT03253536
Lead Sponsor Ludwig-Maximilians - University of Munich
Conditions Hepatocellular Cancer, Quality of Life, Stereotactic Body Radiation Therapy, Observational
Enrollment 100 participants
Start Date 2017-07-10
Primary Completion 2022-07-10 (estimated)
Study Completion 2027-07-10 (estimated)
Updated on ClinicalTrials.gov 2017-08-18